Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I , Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of EGT0001474 In Healthy Volunteers

NCT00854113 is registered in ClinicalTrials.gov with Theracos as lead sponsor.

NCT NCT00854113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00854113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I , Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of EGT0001474 In Healthy Volunteers
Lead sponsor
Theracos
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2009
Completion date
July 31, 2009
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety and tolerability of egt0001474 in healthy volunteers